Randomized Controlled Trial of Rituximab and Cost-Effectiveness Analysis in Treating Fatigue and Oral Dryness in Primary Sjögren's Syndrome
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Randomized Controlled Trial of Rituximab and Cost-Effectiveness Analysis in Treating Fatigue and Oral Dryness in Primary Sjögren's Syndrome
Authors
Keywords
-
Journal
Arthritis & Rheumatology
Volume 69, Issue 7, Pages 1440-1450
Publisher
Wiley
Online
2017-03-11
DOI
10.1002/art.40093
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Development of the Sjögren’s Syndrome Responder Index, a data-driven composite endpoint for assessing treatment efficacy
- (2015) Divi Cornec et al. RHEUMATOLOGY
- Brief Report: Ultrasonographic Assessment of Salivary Gland Response to Rituximab in Primary Sjögren's Syndrome
- (2015) Sandrine Jousse-Joulin et al. Arthritis & Rheumatology
- Treatment of Primary Sjögren Syndrome With Rituximab
- (2014) Valérie Devauchelle-Pensec et al. ANNALS OF INTERNAL MEDICINE
- The TRACTISS Protocol: a randomised double blind placebo controlled clinical TRial of Anti-B-Cell Therapy In patients with primary Sjögren’s Syndrome
- (2014) Sarah Brown et al. BMC MUSCULOSKELETAL DISORDERS
- Effects of Hydroxychloroquine on Symptomatic Improvement in Primary Sjögren Syndrome
- (2014) Jacques-Eric Gottenberg et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- EULAR Sjögren's Syndrome Disease Activity Index (ESSDAI) is sensitive to show efficacy of rituximab treatment in a randomised controlled trial
- (2013) R V Moerman et al. ANNALS OF THE RHEUMATIC DISEASES
- Rituximab Therapy for Primary Sjögren's Syndrome: An Open-Label Clinical Trial and Mechanistic Analysis
- (2013) E. William St.Clair et al. ARTHRITIS AND RHEUMATISM
- Efficacy and safety of rituximab treatment in early primary Sjögren's syndrome: a prospective, multi-center, follow-up study
- (2013) Francesco Carubbi et al. ARTHRITIS RESEARCH & THERAPY
- EULAR Sjogren's Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjogren's syndrome
- (2011) R. Seror et al. ANNALS OF THE RHEUMATIC DISEASES
- Effectiveness of rituximab treatment in primary Sjögren's syndrome: A randomized, double-blind, placebo-controlled trial
- (2010) J. M. Meijer et al. ARTHRITIS AND RHEUMATISM
- Multiple imputation using chained equations: Issues and guidance for practice
- (2010) Ian R. White et al. STATISTICS IN MEDICINE
- EULAR Sjogren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren's syndrome
- (2009) R. Seror et al. ANNALS OF THE RHEUMATIC DISEASES
- Reduction of fatigue in Sjogren syndrome with rituximab: results of a randomised, double-blind, placebo-controlled pilot study
- (2008) S Dass et al. ANNALS OF THE RHEUMATIC DISEASES
- Patient-reported outcomes in primary Sjogren's syndrome: comparison of the long and short versions of the Profile of Fatigue and Discomfort--Sicca Symptoms Inventory
- (2008) S. J. Bowman et al. RHEUMATOLOGY
- The Sjogren's Syndrome Damage Index--a damage index for use in clinical trials and observational studies in primary Sjogren's syndrome
- (2008) R. J. Barry et al. RHEUMATOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started